Invitation to Cover: Major New Initiative to Defeat Pediatric Brain Tumors to be Announced at National Press Club

Model will fundamentally change the way pediatric cancer research and
drug discovery is funded and conducted

–(BUSINESS WIRE)–#braintumors–National Brain Tumor Society (NBTS):

 

WHAT

 

Launch of Project Impact: A Campaign to Defeat Pediatric Brain
Tumors

 

WHEN

Monday, September 12, 2016

Press Event: Noon – 1:00 PM (Media Registration: 11:45 AM)
Reception: 1:30 – 3:00 PM
 

WHERE

National Press Club, 529 14th Street NW, 13th
Floor, Washington, D.C. 20045

 

WHO

National Brain Tumor Society (NBTS) and several world renowned
experts in the field of pediatric neuro-oncology

 

SPEAKERS

David Arons, JD: CEO, National Brain Tumor Society;
President Pediatric Cancer Cure, LLC; Member, Blue Ribbon Panel,
Cancer Moonshot Initiative; Chair, National Cancer Institute’s
National Council of Research Advocates

 

Roger J. Packer, MD: Senior VP of the Center for
Neuroscience and Behavioral Medicine and Director of Brain Tumor
Institute at Children’s National Medical Center; Scientific
Director, Defeat Pediatric Brain Tumors Research Collaborative

 

Suzanne J. Baker, PhD: Director of the Brain Tumor Research
Division, Co-Leader of the Neurobiology & Brain Tumor Program, and
Endowed Chair in Brain Tumor Research at St. Jude Children’s
Research Hospital; Principle Investigator within the Defeat
Pediatric Brain Tumors Research Collaborative

 

Raphaël Rousseau, MD, PhD – Group Medical Director / Global
Franchise Head, Pediatrics, Genentech, a member of the Roche Group

 

Cord Schlobohm: Father of child lost to pediatric brain
tumor and pediatric brain tumor research advocate; recently served
as a patient advocate on the Peer-Reviewed Cancer Research Program
of the Department of Defense’s Congressionally Directed Medical
Research Fund.

 

WHY

More than 4,600 children and adolescents (ages 0-19) will be
diagnosed this year with a brain tumor, the most prevalent form of
pediatric cancer. Brain tumors surpass leukemia as the deadliest
form of cancer for kids under age 14. NBTS will announce details of
a capital campaign that will provide sustainable support for
research into pediatric brain tumors and promote a new model of
collaboration and data-sharing within the pediatric neuro-oncology
community to expedite discoveries and their translation toward new
treatments.

About National Brain Tumor Society

National Brain Tumor Society (NBTS) is the largest nonprofit
organization in the US dedicated to the brain tumor community. We are
committed to finding better treatments and driving progress toward a
cure for brain tumors. We drive a multi-faceted and thoughtful approach
to influence and fund strategic research, as well as advocate for policy
changes, to achieve the greatest impact, results, and progress for brain
tumor patients. Money raised by the donations of our supporters directly
funds groundbreaking discoveries, programs, clinical trials and policy
initiatives. Learn more at www.braintumor.org

Contacts

National Brain Tumor Society (NBTS):
Media Contacts:
Tom
Halkin, 617-393-2849
thalkin@braintumor.org
or
Michael
Antonellis, 617-393-2841
mantonellis@braintumor.org